Kelsey A. Holdaway

Computer ScienceMedicineNeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Bioactive recombinant human oncostatin M for NMR-based screening in drug discovery”.

Bioactive recombinant human oncostatin M for NMR-based screening in drug discovery

Scientific Reports(2021)10.1038/s41598-021-95424-6

N/A

0DataRank · unranked

9 citations

Joseph P. Tuccinardi, Luke Woodbury, Cody Wolf, Bri Grantham, Kelsey A. Holdaway +6 more

Discovery of a Pan-Melanocortin Receptor Antagonist [Ac-DPhe(pI)-Arg-Nal(2′)-Orn-NH2] at the MC1R, MC3R, MC4R, and MC5R that Mediates an Increased Feeding Response in Mice and a 40-Fold Selective MC1R Antagonist [Ac-DPhe(pI)-DArg-Nal(2′)-Arg-NH2]

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00432

N/A

0DataRank · unranked

3 citations

Linh T. Tran, Sarah S. Mathre, Katie T. Freeman, Kelsey A. Holdaway, Kristen John +4 more

Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception

Future Medicinal Chemistry(2025)10.1080/17568919.2025.2463868

N/A

0DataRank · unranked

3 citations

Kelsey A. Holdaway, Maryam Nazari, Laila Aiad, Bidisha Sarkar, Gunda I. Georg +1 more

Development of the First Small-Molecule Inhibitor Targeting Oncostatin M for Treatment of Breast Cancer

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.4c03233

N/A

0DataRank · unranked

2 citations

Andrea Feci, Joseph P. Tuccinardi, Grace H. Coughlin, Kelsey A. Holdaway, Thaaer Muhammed +17 more